Menu
Logo

Mean Patient Preference Weights For Treatment Goals In Schizophrenia

header-Trevicta
Mean_patient_preference_weights

Adapted from Bridges J et al. 2018.
* Preference weights are ratio data (10% is twice as important as 5%); sum of preference weights is 100%; 95% CIs shown.1
CI, confidence interval.

This study seeks to quantify the treatment goals of people recently diagnosed with schizophrenia and explore their impact on treatment plan.
100 patients aged 18 to 35 with confirmed primary diagnosis of schizophrenia according to diagnostic and Statistical Manual of Mental Disorders, Fifth Edition®; < 5 years since diagnosis of schizophrenia were recruited from 5 clinical centers across Europe to complete an online survey in their native language. Best–worst scaling (BWS) object case was chosen to assess preferences for 13 treatment goals.5

References
1. INVEGA® Ministry of Health approved leaflet, 18/3/2019.
2. Risperdal® Ministry of Health approved leaflet, 16/12/2019.
3. INVEGA SUSTENNA® Ministry of Health approved leaflet, 18/3/2019.
4. TREVICTA® Ministry of Health approved leaflet.19/5/2019.
5. Bridges JF, Beusterien K, Heres S, et al. Quantifying the treatment goals of people recently diagnosed with schizophrenia using best-worst scaling.
Patient Prefer Adherence. 2018;12:63-70.

footer-Trevicta

CP-242848